Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial

BACKGROUND: Patients with permanent atrial fibrillation have poor outcomes, exercise capacity, and quality of life even on optimal anticoagulation. Based on mechanistic and observational data, we tested whether the mineralocorticoid receptor antagonist spironolactone can improve exercise capacity, E...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Heart Assoc
Main Authors: Shantsila, Eduard, Shahid, Farhan, Sun, Yongzhong, Deeks, Jonathan, Calvert, Melanie, Fisher, James P., Kirchhof, Paulus, Gill, Paramjit S., Lip, Gregory Y. H.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7726985/
https://ncbi.nlm.nih.gov/pubmed/32909497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.016239
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker